Tetrahydrocannabivarin

from Wikipedia, the free encyclopedia
Structural formula
Structural formula of tetrahydrocannabivarin
General
Surname Tetrahydrocannabivarin
other names

THCV

Molecular formula C 19 H 26 O 2
External identifiers / databases
CAS number 28172-17-0
PubChem 34180
Wikidata Q254768
Drug information
Drug class

Cannabinoids

properties
Molar mass 286.41 g mol −1
safety instructions
GHS hazard labeling
no classification available
As far as possible and customary, SI units are used. Unless otherwise noted, the data given apply to standard conditions .

Tetrahydrocannabivarin ( THCV ) is a cannabinoid . It has a similar basic structure to tetrahydrocannabinol (THC).

Medical application

The effects of tetrahydrocannabivarin could be used in combination with metformin diabetics.

literature

  • RG Pertwee: The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. In: British journal of pharmacology. Volume 153, Number 2, January 2008, pp. 199-215, doi : 10.1038 / sj.bjp.0707442 , PMID 17828291 , PMC 2219532 (free full text) (review).
  • D. Bolognini, B. Costa et al. a .: The plant cannabinoid Delta9-tetrahydrocannabivarin can decrease signs of inflammation and inflammatory pain in mice. In: British journal of pharmacology. Volume 160, number 3, June 2010, pp. 677-687, doi : 10.1111 / j.1476-5381.2010.00756.x , PMID 20590571 , PMC 2931567 (free full text).
  • JM McPartland, M. Duncan, et al. a .: Are cannabidiol and Δ (9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review. In: British journal of pharmacology. Volume 172, number 3, February 2015, pp. 737-753, doi : 10.1111 / bph.12944 , PMID 25257544 , PMC 4301686 (free full text) (review).

Web links

Individual evidence

  1. ↑ This substance has either not yet been classified with regard to its hazardousness or a reliable and citable source has not yet been found.
  2. ↑ globenewswire: GW Pharmaceuticals Provides Update on Cannabinoid Pipeline Nasdaq: GWPH , accessed December 13, 2015.
  3. ↑ ET Wargent, MS Zaibi, C. Silvestri, DC Hislop, CJ Stocker, CG Stott, GW Guy, M. Duncan, V. Di Marzo, MA Cawthorne: The cannabinoid Δ (9) -tetrahydrocannabivarin (THCV) ameliorates insulin sensitivity in two mouse models of obesity. In: Nutrition & Diabetes. Volume 3, 2013, p. E68, doi : 10.1038 / nutd.2013.9 , PMID 23712280 , PMC 3671751 (free full text).